Episode 18 | Fred Marroni
Strategizing in order to power your business through the pandemic is, by now, par for the course. But when a company reports a record first quarter in 2021, they may have found something special.
Fred Marroni, President and CEO of Indigo Biosciences, a State College-based company offering products and services focused around nuclear receptors, reveals the practices that have fueled his growth throughout the past year.
Now streaming on Spotify, Apple Podcasts, and Google Podcasts.
About Fred Marroni
Fred Marroni, President and CEO of INDIGO Biosciences, is a successful entrepreneur with more than 25 years of executive management and engineering experience. His career has spanned multiple industries, technologies, and organization stages including turn-around management of an Internet technologies company that had 100% growth of a $15 million business unit within 24 months. His attention to details, team motivational skills and operational experience were key factors in this accomplishment. His expertise ranges from being the founding executive of several companies to senior management of a Fortune 1000 business. He has lead efforts in merger and acquisitions and contract negotiations. For the past 10 years, he has focused on evaluating and funding of early stage life science companies.
In his first two years at Clarion Research Group as Chief Operating Officer, Fred led early stage funding that exceeded $3 million. During this time, he helped to develop go-to-market strategies for two medical products that will launch within 18 months of the funding. Prior to his role at Clarion Research Group, he was an executive with the Pittsburgh Life Sciences Greenhouse (PLSG), an economic development organization responsible for due diligence and investments across 25 portfolio companies. As a result of his efforts with many entrepreneurs, companies within his portfolio raised more than $7 million in grants and angel funding. Several of the early stage companies that he was associated with have collectively raised more than $12 million in funding. Fred earned his Bachelor of Science in Industrial Engineering from Penn State University and his Operations Management certificate from Union Pacific Corporation.
About INDIGO Biosciences
INDIGO Biosciences, Inc. is a leading provider of nuclear receptor and in vitro toxicology solutions that accelerate scientific decision-making. They supplement the world’s largest portfolio of nuclear receptor kits and services and in vitro toxicology solutions with greater results readability, reproducibility, and faster turnaround times. Their solutions, supportive team, and reliable science and platforms aim to reduce the time, cost, and risk associated with the discovery process.
Connect with Fred Marroni
About Pittsburgh Business Insights
Starting a business: three words that require plenty of planning. On Pittsburgh Business Insights, The Lynch Law Group interviews Pittsburgh entrepreneurs and uncovers what makes business boom in the Steel City. Whether you are growing your own company, looking to improve your practices, or simply interested in the advice of Pittsburgh professionals, tune in for ideas and inspiration from Pittsburgh’s top business leaders.